NCT01014312

Brief Summary

This research study develop a collaborative depression care management model (C-DCM) that encourages collaboration between primary care physicians (PCPs) and trained social workers employed by community-based, public and nonprofit mental health clinics.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable depression

Timeline
Completed

Started Sep 2009

Longer than P75 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 3, 2009

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 16, 2009

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2015

Completed
Last Updated

February 23, 2017

Status Verified

February 1, 2017

Enrollment Period

5.7 years

First QC Date

November 3, 2009

Last Update Submit

February 17, 2017

Conditions

Keywords

Depression

Outcome Measures

Primary Outcomes (1)

  • Reduction in severity of depression over 16 weeks as measured by the Montgomery Asberg Depression Rating Scale (MADRS).

    Measured at Baseline, 8 weeks, and 16 weeks

Secondary Outcomes (1)

  • Reduction in disability over 16 weeks as measured by the World Health Organization Disability Scale (WHODAS).

    Measured at Baseline, 8 weeks, and 16 weeks

Study Arms (2)

Depression Care Management (DCM)

EXPERIMENTAL

Participants will receive Depression Care Management.

Behavioral: Depression Care Management (DCM)

Enhanced Care

ACTIVE COMPARATOR

Participants will receive the standard of care from their primary care physicians enhanced by a summary of the study's diagnostic interview.

Behavioral: Enhanced Care

Interventions

Depression Care Management (DCM) includes: 1. Monitoring the course of the depressive disorder; 2. Contacting the referring primary care physician (PCP) and offering information on the patients' current psychiatric status and medical complaints and the treatment recommended by published pharmacotherapy guidelines; 3. Determining the nature and extent of stressors affecting the patients' clinical status and functioning; 4. Psychoeducation concerning depression and depression treatment, working with the patient to select an appropriate treatment based on informed treatment preferences, and emphasizing treatment adherence; and 5. Supportive psychotherapy.

Depression Care Management (DCM)
Enhanced CareBEHAVIORAL

Primary Care Physicians will be informed by letter from a study psychologist of the participants' depression diagnosis and of suicidal ideation when present. They will have no direct assistance regarding depression treatment, but they will be educated on guideline-based antidepressant treatment recommendations. Moreover, research assistants will use a suicide risk protocol at baseline and at all follow-up assessment periods that mandates immediate contact with PCPs by telephone or beeper in cases with significant risk.

Enhanced Care

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 years and older: This study focuses on the clinical complexities of late-life depression and its treatment. Family Services of Westchester (our partner community mental health agency) offers geriatric mental health counseling services to adults age 60 and older.
  • Diagnosis of unipolar major depression
  • MADRS score \>=18: Depression of such severity in primary care patients requires treatment.
  • CANE score \>0: Reflects the presence of at least one unmet need in the domains of housing, self-care, safety, finances, benefits, legal matters, transportation, etc. and thus need for social services.
  • Capacity to provide written consent for both research assessment and depression care management: PCPs will be asked to clinically evaluate prospective participants' capacity to consent and document it in their medical record.
  • Working knowledge of English: Command in English sufficient for comprehending questionnaires of the study and/or for understanding the DCM therapists. English does not have to be the subject's first language.

You may not qualify if:

  • Psychotic depression: This will be determined by the Structured Clinical Interview for DSM Disorders(SCID) assessment; presence of delusions and or hallucinations. This is a severe disorder typically referred for treatment to mental health specialists.
  • Active suicidal ideation: This will be determined by the SCID and MADRS assessments. Older patients at these levels of risk for self-harm typically are referred to mental health specialists.
  • Antisocial personality by Diagnostic and Statistical Manual of Mental Disorders (DSM)IV: This disorder will possibly interfere with adherence to research procedures and treatment.
  • Significant Cognitive Impairment (MMSE score \<24) or clinical diagnosis of dementia by DSM-IV: These conditions may limit the patient's ability to participate in treatment and require social service interventions exceeding those available through the proposed depression care management models.
  • Current participation in specialist psychiatric care: Such patients will require the development of collaborative arrangements for depression care management which differ from those being tested in this study.
  • Acute or severe medical illness: i.e., delirium, metastatic cancer, decompensated cardiac, liver or kidney failure, major surgery, stroke or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g., steroids, reserpine, alpha-methyl-dopa, tamoxifen, vincristine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Westchester Medical Group Practices

White Plains, New York, 10605, United States

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Jo Anne Sirey, Ph.D.

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
  • George S. Alexopoulos, M.D.

    Weill Medical College of Cornell University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 3, 2009

First Posted

November 16, 2009

Study Start

September 1, 2009

Primary Completion

April 30, 2015

Study Completion

April 30, 2015

Last Updated

February 23, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

Locations